Healthcare

The share price of Oceania Healthcare Ltd (ASX:OCA) declined 0.81% to AUD 0.61 during the afternoon trading session on 21 July 2026. While short-term market movements often capture investor attention, experienced market participants generally assess daily price changes alongside the company's long-term operating performance, …

Telix Pharmaceuticals Limited (ASX: TLX) traded higher during intraday dealings on 21 July 2026 after releasing its second-quarter business update. Investors responded to continued revenue growth, with the company reporting stronger sales across its commercial imaging portfolio while maintaining its full-year revenue guidance. The …

PYC Therapeutics Limited (ASX: PYC) traded lower during intraday trading on 21 July 2026 as investors continued assessing clinical-stage biotechnology companies amid broader market volatility. The decline occurred without any confirmed company-specific announcement, with the movement appearing consistent with the day-to-day fluctuations often seen …

Saluda Medical, Inc. (ASX: SLD) traded lower during intraday dealings on 21 July 2026 as investors continued assessing recently listed healthcare companies. The decline occurred without any confirmed company-specific announcement, with broader weakness across emerging medical technology stocks appearing to influence trading sentiment. The …

Oneview Healthcare PLC (ASX: ONE) traded lower during intraday trading on 21 July 2026 as investors continued navigating volatility across smaller healthcare technology companies. The decline occurred without any confirmed company-specific announcement, with the movement appearing against a backdrop of relatively thin trading volumes …

Mesoblast Limited (ASX: MSB) traded around 4.5% lower during intraday trading on 21 July 2026 as investors reassessed the biotechnology company's recent share-price rally. The decline occurred without any confirmed company-specific announcement, with the softer session following strong gains recorded after the company's latest …

EBR Systems, Inc. (ASX: EBR) traded about 4.3% lower during intraday trading on 21 July 2026, extending recent weakness in the medical technology company's share price. The decline occurred without any confirmed company-specific announcement, with investors instead continuing to assess the company's commercial rollout, …